This is a single-center, double-arm, patient masked, randomized controlled trial. Subjects will be enrolled in the Emergency Department at the Penn State Milton S. Hershey Medical Center. Eligible subjects must present to the ED and be diagnosed with a traumatic corneal abrasion. One eye from each patient will be considered the study eye.
Male or female, age 18 or older at the time of study enrollment.
Corneal abrasion in one eye.
Willingness to sign the IRB-approved informed consent form (ICF) for study participation.
Availability, willingness, and sufficient cognitive awareness to return for study-required visits and comply with examination procedures.
Corneal abrasion in both eyes.
Allergy to moxifloxacin or other fluoroquinolone antibiotics.
Allergy to ibuprofen or other non-steroidal anti-inflammatory drugs.
History of neurotrophic cornea for any reason, in the study eye.